Answers are grounded in this paper and cite their sources.
Examining pitfalls in antiseizure drug selection, highlighting implications for patient outcomes.
Choosing an appropriate antiseizure drug requires careful clinical judgment, and several common pitfalls can adversely affect outcomes. The most frequent error is misclassification of seizure type or epilepsy syndrome. Treating focal and generalized epilepsies interchangeably may worsen seizures—for example, sodium channel blockers can aggravate absence or myoclonic seizures. Another major mistake is treating electroencephalographic abnormalities rather than the clinical seizure semiology. Failure to consider patient-specific factors is equally important. Age, comorbidities (depression, obesity, migraine, cognitive impairment), and organ function significantly influence drug selection. In elderly patients, pharmacokinetic changes increase sensitivity to adverse effects. In women of childbearing potential, teratogenic risk—especially with valproate—must guide decision-making. Publication History Article published online: 15 July 2026 © 2026. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/) Thieme Medical and Scientific Publishers Private Limited A-13A, Graphix Tower 1, 6th floor, Sector 62, Noida 201309, Uttar Pradesh, India
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: